Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.47 USD | -1.96% | -6.13% | +32.33% |
24/05 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
21/05 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
Sales 2024 * | 754M 62.69B | Sales 2025 * | 826M 68.74B | Capitalization | 2.85B 237B |
---|---|---|---|---|---|
Net income 2024 * | -395M -32.86B | Net income 2025 * | -194M -16.14B | EV / Sales 2024 * | 3.12 x |
Net cash position 2024 * | 503M 41.88B | Net cash position 2025 * | 424M 35.25B | EV / Sales 2025 * | 2.94 x |
P/E ratio 2024 * |
-7.1
x | P/E ratio 2025 * |
-13.4
x | Employees | 1,022 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.58% |
Latest transcript on PTC Therapeutics, Inc.
1 day | -1.96% | ||
1 week | -6.13% | ||
Current month | +13.44% | ||
1 month | +27.65% | ||
3 months | +29.33% | ||
6 months | +66.61% | ||
Current year | +32.33% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 52 | 01/19/01 |
Pierre Gravier
DFI | Director of Finance/CFO | 39 | 13/23/13 |
Ellen Welch
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Steele
BRD | Director/Board Member | 79 | 15/15/15 |
Chairman | 72 | 01/01/01 | |
David Southwell
BRD | Director/Board Member | 63 | 01/05/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.35% | 14 M€ | -4.84% | ||
0.36% | 0 M€ | 0.00% | - | |
0.25% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
28/24/28 | 36.47 | -1.96% | 844,772 |
24/24/24 | 37.2 | +0.19% | 540,532 |
23/24/23 | 37.13 | -3.91% | 848,100 |
22/24/22 | 38.64 | -0.54% | 1,085,656 |
21/24/21 | 38.85 | -3.17% | 1,357,523 |
Delayed Quote Nasdaq, May 29, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.33% | 2.85B | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- PTCT Stock